Kidney transplantation – colour doppler and contrast-enhanced ultrasound in the early postoperative assessment of delayed graft function: retrospective results and pilot prospective findings Authors: Matteo Zanchetta, Marika Morabito, Marta Ripamonti, Linda Liepa, Valentina Iori, Gian Luigi Adani, Andrea Coppola, Federico Fontana, Davide Inversini, K. T.-CEUS Workgroup, Giulio Carcano, Giuseppe Ietto Published: 2026 ABSTRACT AbstractIntroductionDelayed graft function (DGF) remains a relevant early complication after kidney transplantation (KT), and reliable non-invasive imaging markers may improve postoperative graft assessment.Materials and methodsWe retrospectively evaluated 381 KT recipients who underwent colour Doppler (CD) ultrasound (US) on postoperative day (POD) 1 and before discharge between January 2013 and February 2022. Resistive index (RI) measurements were analyzed in relation to DGF, defined as the need for at least one dialysis session within the first postoperative week. A prospective pilot subgroup of 25 recipients transplanted between February 2021 and February 2022 also underwent contrast-enhanced US (CEUS) between POD 1 and 3, with analysis of wash-in slope (WIS), time to peak (TTP), peak intensity (PI), and area under the curve (AUC).ResultsIn the retrospective cohort, 71 (18.6%) developed DGF. Higher RI values on POD 1 and before discharge were significantly associated with DGF. In the CEUS pilot subgroup, 7 patients (28.0%) developed DGF. Among CEUS-derived parameters, AUC was significantly associated with DGF, with lower values in patients who developed DGF and a valuable ROC AUC of 0.794.ConclusionsThese findings support a role for early postoperative CD in graft function assessment and suggest that CEUS-derived AUC may provide valuable complementary information in the early evaluation of grafts for DGF. However, the CEUS results are exploratory and require validation in larger prospective studies.Keywords: Contrast-enhanced ultrasound, Kidney transplantation, Kidney transplant, Delayed graft function, Echocolour doppler, Ultrasound, DGF, ECD, CEUS Introduction Chronic kidney disease (CKD) is a clinical syndrome resulting from multiple pathophysiological processes, including diabetes mellitus, arterial hypertension, chronic obstructions, autosomal dominant polycystic kidney disease and other congenital nephropathies, glomerulonephritis, and pyelonephritis [1]. Chronic kidney disease is characterised by a progressive and irreversible deterioration of the renal structure and function, which is also reflected by a decline in glomerular filtration rate (GFR) [2]. The terminal stage of CKD is end-stage renal disease (ESRD), or kidney failure, which requires dialysis or kidney transplantation (KT) [3, 4]. Dialysis should be regarded as a provisional treatment, to be employed in the interval preceding the receipt of a compatible renal transplant. For decades, KT has been the gold standard treatment for ESRD patients [5, 6]. The number of ESRD patients is rising worldwide, underscoring the critical need to optimize the utilization of all the renal grafts potentially available [7, 8]. In the immediate postoperative period after KT, more than 80% of renal allografts demonstrate adequate early function, reflected by improving serum creatinine levels and satisfactory urine output. However, a smaller proportion of recipients experience early graft dysfunction as DGF [9–11]. The incidence of DGF is more frequent in grafts from marginal or deceased donors [12]. Although DGF remains a clinically relevant early complication that may associate with adverse graft and patient outcomes [13], it should not necessarily be regarded as a reason to avoid the use of certain higher-risk grafts, since shorter-duration DGF has not been associated with inferior long-term graft or patient survival [14]. An even smaller percentage may experience a primary non-function (PNF), requiring graft explantation or a new KT. Therefore, reliable early assessment of graft function is clinically relevant. In this context, postoperative imaging may complement clinical and laboratory findings by improving the early evaluation of graft dysfunction and supporting patient monitoring and management in the days after transplantation [15]. Ultrasonography (US) and Colour Doppler (CD) US are the most commonly used imaging modalities for the postoperative assessment of renal allografts because they are non-invasive, widely available, reproducible, and relatively inexpensive. In selected cases, contrast-enhanced ultrasound (CEUS) may provide additional information on graft parenchyma and vascular status, allowing a reliable quantitative analysis of renal microvascularisation [16]. In the present study, our primary aim was to evaluate the potential association between early postoperative CD parameters and DGF after KT. Our secondary aim was to explore, in a pilot prospective subgroup, the potential value of CEUS-derived parameters as preliminary imaging markers for early graft function assessment, with possible future relevance for postoperative monitoring and clinical decision-making. Materials and methods Study design and population The study included two populations: a retrospective cohort of 381 consecutive KT recipients who underwent standard postoperative US assessment, and a prospective pilot subgroup of 25 recipients who, in addition to standard US assessment, also underwent CEUS evaluation. The retrospective cohort included patients who underwent KT at the Emergency and Transplant Surgery Unit of the Ospedale di Circolo in Varese between 1 st of January 2013 and 28th of February 2022. The prospective subgroup included patients transplanted between 1 st of February 2021 and 28th of February 2022. Data collection Data collected included demographic characteristics (sex, age at transplantation, body mass index (BMI), Charlson comorbidity index of the recipient), clinical and laboratory variables (serum creatinine and haemoglobin (Hb) at admission, residual diuresis, type and duration of dialysis), transplant-related variables (single- or double-graft transplantation, duration of surgery, mean arterial pressure at declamping, postoperative Hb, time to recovery of renal function, duration of hospital stay, serum creatinine at discharge), and donor/graft-related variables (donor age, donor Charlson score, cold ischemia time, Karpinski score). Short-term transplant outcomes were also recorded. US and CD protocol All US, CD and CEUS examinations were performed by the same experienced radiologists, already versed in post-KT evaluation, thus reducing inter-operator variability and ensuring consistency in acquisition and analysis. All patients in the retrospective cohort underwent CD US examinations using a Philips® EPIQ 7 device. Examinations were performed on postoperative day (POD) 1, POD 4, and before discharge. For the present analysis, examinations performed on POD 1 and before discharge were considered, in order to evaluate both immediate postoperative perfusion and graft status at the end of hospitalization. Several parameters were considered, focusing on indices of resistance (RI) at different moments of the examination: the maximum RI (RI Max), the minimum RI (RI Min), four intermediate RIs (RI Int 1, 2, 3, and 4), and the median RI (RI M). All RI measurements were obtained from intrarenal segmental or interlobar vessels within the graft parenchyma, where the thinnest vascular branches could be evaluated, with care taken to minimize the Doppler angle and optimize signal quality. Measurements of RI were obtained from intrarenal segmental or interlobar arteries. CEUS protocol In the prospective subgroup, patients underwent combined standard bidimensional (B-mode) US and CEUS between POD 1 and POD 3, depending on clinical conditions and scanner availability. CEUS was performed using the same Philips® EPIQ 7 device. To prepare the CEUS scan, one bolus of 1 mL of Sulfur Hexafluoride was intravenously injected (SonoVue® Bracco), followed by 5 mL of 0.9% NaCl saline. The procedure was evaluated by video recording for one minute immediately after contrast injection. The monitor was set for comparison in head-to-head mode, with B-mode side-by-side with contrast-enhanced mode. Image acquisition was optimized by adjusting depth, focus, and gain settings to ensure adequate visualization of the graft parenchyma. Patients were examined in supine position, and acquisition was performed during quiet breathing to minimize motion artefacts. For CEUS analysis, a 10-mm region of interest (ROI) was identified at the upper pole of the graft and maintained throughout the examination. The following four CEUS-derived parameters were recorded: wash-in slope (WIS, dB/s), defined as the slope of the curve in the filling phase, measured in decibels per second; time to peak (TTP, s), defined as the time from the baseline (i.e. zero intensity), immediately before the contrast agent reaches the ROI, to maximum intensity, measured in seconds; peak intensity (PI, dB), measured in decibels; area under the curve (AUC), defined as the area under the time-intensity curve above baseline. Data obtained from CEUS were analysed using QLAB software to obtain a quantitative analysis (Fig. 1). Comparison in head-to-head mode, with CEUS (left) side-by-side with B-mode (right). Image recorded 28 s after the injection of contrast medium Definitions Delayed graft function was defined as the need for at least one dialysis session within the first week after transplantation. Primary non-function was defined as irreversible absence of graft function from the time of transplantation, resulting in permanent dialysis requirement and/or graft explantation or retransplantation. Graft loss was defined as cessation of function (i.e. permanent return to dialysis), or death of the patient. Outcomes The primary objective of the study was to assess the association between early postoperative CD-derived RI values and the occurrence of DGF and PNF. As a secondary objective, CEUS-derived perfusion parameters were explored in the pilot prospective substudy as potential adjunct imaging markers of early graft dysfunction. Statistical analysis To combine an overall clinical assessment of the patient with analytical and radiological data closely related to the transplanted organ, it was decided to perform a kidney-based statistical analysis focusing on the graft. Descriptive statistical analysis was performed for demographic, clinical, laboratory, and US variables. Normality was assessed by the Shapiro–Wilk test. Normally distributed continuous variables are reported as mean ± standard deviation (SD), whereas non-normally distributed variables are reported as median and interquartile range (IQR). Categorical variables are presented as counts and percentages. Group comparisons were performed using the Mann–Whitney U test. For comparisons involving normally distributed continuous variables, including WIS in the CEUS pilot subgroup, Student’s t-test was used. Receiver operating characteristic (ROC) curve analysis was performed to assess the performance of imaging parameters. All statistical analyses were conducted using SPSS version 25.0 (IBM Corp., Armonk, NY, USA). All tests were two-sided, and a P value < 0.05 was considered statistically significant. No formal sample size calculation was performed, as the retrospective cohort included all consecutive eligible patients during the study period; the CEUS subgroup was considered exploratory. Analyses were performed using available data, and no imputation was applied. Results The retrospective arm included 381 KTs, including 367 single-graft KTs and 14 double-graft KTs, for a total of 395 renal grafts, between the 1 st of February 2013 and the 28th of February 2022. Table 1 summarizes baseline characteristics of the retrospective cohort. All reported variables had a non-normal distribution. Delayed graft function developed in 71 cases (18.6%). Of these, 52 occurred in male recipients (73.2%), including 4 double-graft KTs, while all female recipients with DGF had undergone single-graft KT. Primary non-function occurred in 10 patients (2.6%) and was equally distributed between male and female recipients. Overall, 8 grafts (2.0%) underwent explantation. Table 1Characteristics of the retrospective cohort. Values are reported as median followed by ± interquartile range and range within brackets, unless otherwise specified. Comparisons between patients with and without DGF were performed using the Mann–Whitney U test, and the respective p value was reported when availableRecipient sex and transplant typeMale recipients, n (% of total)257 (67.5%)Male recipients with single-graft KT, n (%)246 (64.6%)Male recipients with double-graft KT, n (%)11 (2.9%)Female recipients, n (%)124 (32.5%)Female recipients with single-graft KT, n (%)121 (31.7%)Female recipients with double-graft KT, n (%)3 (0.8%)Recipient characteristicsAssociation with DGF (p value)Age at transplantation, years55 (± 18) (19–76)p = 0.001Body mass index, kg/m224.65 (± 5.40)p = 0.006Serum creatinine at admission, mg/dL7.21 (± 3.12) (2.83–15.81)Residual diuresis, cc/day50.00 (± 12.00)Duration of dialysis, years3.00 (± 3.00)Hemodialysis, n (%)242 (63.5%)Peritoneal dialysis, n (%)116 (30.4%)Pre-emptive, n (%)23 (6.1%)Hemoglobin at admission, g/dL11.90 (± 2.18)Recipient Charlson Comorbidity Index (n = 373)4 (± 2) (0–10)Donor/graft characteristicsAssociation with DGF (p value)Donor age, years57 (± 18) (16–88)p = 0.005Donor Charlson Comorbidity Index2 (± 2) (0–6)Karpinski score (organs n = 82)3 (± 2) (0–6)Cold ischemic time, min (organs n = 348)732 (± 334)p < 0.001Transplant-related characteristicsAssociation with DGF (p value)Duration of surgery, min (n = 332)p < 0.001Mean arterial pressure at declamping, mmHg (n = 378)225.50 (± 87)p < 0.001Postoperative hemoglobin, g/dL89.65 (± 15)Serum creatinine at discharge, mg/dL10.90 (± 1.60)p < 0.001 Characteristics of the retrospective cohort. Values are reported as median followed by ± interquartile range and range within brackets, unless otherwise specified. Comparisons between patients with and without DGF were performed using the Mann–Whitney U test, and the respective p value was reported when available The average CD-derived RI (n = 389/395) are reported in Table 2. Table 2Indices of resistance measured during CD scans (389/395 grafts)POD 1Pre-dischargeRI Max0.72 ± 0.110.76 ± 0.10RI Min0.65 ± 0.110.70 ± 0.11RI M0.69 ± 0.110.73 ± 0.10 Indices of resistance measured during CD scans (389/395 grafts) The Mann–Whitney U test was used to compare imaging parameters between grafts with immediate graft function and those that developed DGF or PNF. RI Max, RI Min, and RI M values on POD 1 were significantly higher in grafts that developed DGF compared with those with immediate graft function (Mann–Whitney U test: p < 0.001, p = 0.001, and p < 0.001, respectively), as were pre-discharge RI values (Mann–Whitney U test: all p < 0.001). ROC analysis showed modest discriminatory performance of CD-derived RI parameters for DGF, with AUC values ranging from 0.631 to 0.682. As shown in Fig. 2 and Table 3, the overall findings suggest a moderate ability of RI measurements to distinguish grafts that developed DGF from those with an immediate positive function after transplantation. ROC analysis for ECD-RI values Table 3Values of the AUC in ROC CD-RI analysisVariablesAreaRI Max POD 10.666RI Min POD 10.631RI M POD 10.649RI Max pre-discharge0.680RI Min pre-discharge0.671RI M pre-discharge0.682S-creatinine (discharge)0.767 Values of the AUC in ROC CD-RI analysis The same analysis was performed to assess the association between CD-derived RI values and the occurrence of PNF. No significant differences in RI parameters were observed between grafts with and without PNF (Mann–Whitney U test; all p > 0.05). Serum creatinine at discharge was significantly higher in patients who developed DGF compared with those with immediate graft function (approximately 2.5 mg/dL [IQR 2.0–3.6] vs 1.5 mg/dL [IQR 1.2–1.9], respectively; Mann–Whitney U test, p < 0.001), as shown in Fig. 3. Median creatinine level at discharge between patients without or with DGF after KT Additional variables significantly associated with DGF on Mann–Whitney U testing included higher recipient BMI (p = 0.006), older recipient age at transplantation (p = 0.001), longer hospital stay (p < 0.001), older donor age (p = 0.005), longer duration of surgery (p < 0.001), and lower mean arterial pressure at declamping (p < 0.001). As expected, time to functional recovery was longer in the DGF group than in the non-DGF group (median 8 days [IQR 8] vs 1 day [IQR 2], respectively). Cold ischemia time in the overall cohort had a median of 732 min (IQR 334). Longer cold ischemia time was significantly associated with both DGF (Mann–Whitney U test, p < 0.001) and PNF (Mann–Whitney U test, p = 0.018). As shown in Fig. 4, grafts that developed PNF had longer cold ischemia times than those with an immediate graft function. Comparison of cold ischemia time values between patients without or with PNF after KT The prospective pilot subgroup included 25 recipients of single-graft KT transplanted between 1 February 2021 and 28 February 2022; 15 (60.0%) were men. Seven (28%) developed DGF, with five being men (71.4% of DGF). This subgroup was also included in the retrospective cohort. WIS was normally distributed with a mean of 2.075 dB/s and a standard deviation (SD) of 0.904 dB/s; no significant difference in WIS was observed between patients with and without DGF using Student’s t-test. TTP, PI, and AUC were non-normally distributed and were analysed using Mann–Whitney U test, considering a p-value < 0.05 for statistical significance. The TTP showed a median (± IQR) of 21.54 ± 13.84 s, with values of maximum and minimum recorded time of 86.86 and 9.69 s, respectively. The PI had a median (± IQR) of 21.95 ± 8.18 dB, with maximum value 78.77 dB and a minimum value of 4.35 dB. No significant differences between DGF and non-DGF patients were observed for TTP (Mann–Whitney U test, p = 0.745) or PI (Mann–Whitney U test, p = 0.125). In contrast, AUC was significantly associated with DGF (Mann–Whitney U test; p = 0.025). Patients who developed DGF had lower AUC values than those with immediate graft function (median 834.21 dBs [± IQR 457.97] vs 1048.75 dBs [± IQR 581.26], respectively), as shown in Fig. 5. Area under the curve of patients who did not develop DGF and patients who developed DGF To further explore the association between CEUS-derived AUC and DGF, ROC analysis was performed, yielding an AUC of 0.794, as shown in Fig. 6. This finding suggests a promising discriminatory performance of CEUS-derived AUC for identifying DGF in this pilot subgroup. ROC curve for the CEUS-derived value AUC of patients who developed DGF Discussion Conventional US and CD are routinely used for postoperative assessment of renal allografts because they are non-invasive, widely available, reproducible, and relatively inexpensive. These techniques provide important information on graft morphology, position, perirenal collections, and arterial and venous flow. However, their ability to assess graft microperfusion is limited. In this context, CEUS may offer additional information by enabling quantitative evaluation of graft perfusion and microvascularization, reaching peripheral vessels as small as 3–8 µm in diameter, while maintaining a favorable safety profile due to the use of a non-nephrotoxic contrast agent [17, 18]. For this reason, CEUS has emerged as a promising adjunct to CD in the early assessment of renal allograft dysfunction. CEUS provides a real-time assessment of graft perfusion and allows dynamic visualization of contrast distribution during the corticomedullary and nephrographic phases. After the medium contrast injection, the corticomedullary phase can be observed to occur between 15 and 30 s, whereby the initially different cortical and medullary perfusion can be discerned. Subsequently, the nephrographic phase ensues, characterised by a more homogeneous enhancement of the entire organ, which persists for an additional 30 to 40 s. The real-time acquisition method allows for the precise representation of the corticomedullary phase in all examinations. In addition, dedicated software enables quantitative analysis of perfusion parameters, which may offer information beyond CD, particularly at the level of graft microperfusion [16, 19–22]. For this reason, CEUS has been proposed as a useful adjunct in the early evaluation of renal allograft dysfunction, especially in patients in whom CT or MRI may be less suitable. The aim of the study was to evaluate whether early postoperative Doppler-derived RI values were associated with DGF and PNF, and how these parameters evolved during hospitalization. In the present study, higher CD-derived RI values, particularly on POD 1, were significantly associated with DGF. Pre-discharge RI values also remained significantly higher in grafts that developed DGF, suggesting that CD abnormalities may persist even after subsequent functional improvement. These findings support the role of CD as a useful tool in the early postoperative assessment of graft at risk of DGF, potentially supporting closer postoperative monitoring and more timely clinical evaluation and decision-making. No significant association was observed between CD-derived RI values and PNF. In addition, several clinical and transplant-related variables were associated with DGF, including older recipient age, higher BMI, older donor age, longer operative time, lower mean arterial pressure at declamping, and longer cold ischemia time. Longer cold ischemia time was also associated with PNF. These findings are consistent with previous reports and support the view that early graft dysfunction reflects a multifactorial process in which imaging findings should be interpreted together with clinical and perioperative variables. CEUS was included in this study because it allows real-time evaluation of graft perfusion and provides information on microvascularization that cannot be fully captured by conventional ultrasound and Doppler alone. In clinical practice, CEUS may also be useful in the assessment of perirenal collections and other postoperative abnormalities, since the behavior of contrast enhancement can help distinguish perfused from non-perfused structures. In the event of anastomotic failure of arterial or venous vessels, or in the case of blood loss from the graft, the contrast agent would leak out with the blood, allowing the haematoma to be discriminated from the renal parenchyma due to the different contrastographic features. These features make CEUS an attractive adjunct technique in the early postoperative evaluation of renal allografts, particularly because it is non-invasive, relatively accessible, and does not require nephrotoxic contrast agents. In our pilot prospective subgroup, WIS, PI, and TTP were not significantly associated with DGF, whereas CEUS-derived AUC showed a significant association with this outcome. ROC analysis yielded an AUC of 0.794, suggesting a promising discriminatory performance for early identification of DGF in this subgroup. However, this finding should be interpreted with caution because of the limited size of the prospective cohort. Accordingly, our data do not support definitive conclusions regarding the clinical utility of CEUS-derived AUC, but they do suggest that this parameter deserves further evaluation in larger prospective studies, as it may be a useful adjunct marker for early postoperative graft assessment and DGF risk evaluation. The CEUS-derived AUC showed more favorable discriminatory performance than CD-derived RI values. Nonetheless, the comparison between CD-derived RI values and CEUS-derived AUC should also be interpreted cautiously. In our study, CD remained useful for early postoperative assessment, as RI values were significantly associated with DGF. At the same time, the pilot CEUS findings suggest that AUC may provide information beyond conventional CD. Rather than supporting replacement of CD by CEUS, our results are more consistent with a complementary role for CEUS in selected patients or in cases where a more detailed assessment of graft perfusion is required. The main strengths of this study are the size of the retrospective cohort and the consistency of imaging acquisition, as all examinations were performed by the same radiology team, thereby reducing inter-operator variability. Both CD and CEUS remain operator-dependent techniques. In particular, quantitative CEUS analysis requires careful standardization of contrast injection timing, image acquisition, and ROI selection, all of which may influence the derived perfusion curves. Nevertheless, some limitations must be acknowledged. First, the study was conducted at a single centre, and the CEUS subgroup was small, which limits statistical power and generalizability. In addition, technical and patient-related factors, including body habitus, bowel gas, vascular access quality, and imaging artefacts, may affect image quality and reproducibility. Finally, our study focused on early postoperative graft function and does not allow conclusions regarding long-term graft or patient outcomes. Larger prospective studies with longer follow-up will be needed to validate these findings and better define the role of CEUS in the postoperative assessment of kidney transplant recipients. Conclusion Early postoperative CD-derived RI findings were significantly associated with DGF after KT, supporting their role in early graft function assessment. In the pilot prospective CEUS subgroup, AUC was the CEUS-derived parameter significantly associated with DGF and showed promising discriminatory performance. Taken together, these findings suggest that CEUS may provide complementary information beyond conventional CD in the early postoperative evaluation of renal grafts, particularly in higher-risk settings. However, the CEUS results should be considered exploratory because of the limited size of the prospective subgroup. Larger prospective studies are needed to validate these findings, better define the role of CEUS in postoperative monitoring after KT, and determine whether CD- and CEUS-derived variables may contribute to the development of future predictive models for DGF and to more individualized clinical decision-making. Acknowledgements The KT-CEUS workgroup* includes all main authors, as well as the following panel of independent experts Andrea Ballabio2, Sebastiano Gerosa2, Niccolò Grappolini2, Domenico Iovino2, Federica Masci2, David Meierruth2, Mauro Oltolina2, Christian Ossola4, Cristiano Parise2, Walter Sirco2, Andrea Vigezzi2, Elia Zani2. Clinical trial number Not applicable. Abbreviations Area under the curve Body mass index Colour Doppler Contrast-enhanced ultrasound Chronic kidney disease Delayed graft function End-stage renal disease Glomerular filtration rate Haemoglobin Interquartile range Index of resistance Kidney transplant Primary non function Post-operative day Receiver operating characteristic Region of interest Time to peak Wash-in slope Authors’ contributions M.Z. conceptualization, original draft preparation, editing; M.M. data curation; M.R. data curation; L.L. data curation; V.I. data curation; G.L.A. review, supervision; A.C. performed the imaging exams, imaging analysis; F.F. performed the imaging exams, imaging analysis, supervision; D.I. supervision; G.C. supervision; G.I. main operating surgeon, conceptualization, methodology, original draft preparation, review, supervision. All authors have read and agreed to the published version of the manuscript. Funding This research received no external funding. Data availability The datasets analysed during the current study are available from the corresponding author on reasonable request. Declarations Ethics approval and consent to participate The study was approved (n° 0119180) by the local institutional review board (Comitato Etico per la Ricerca). Written informed consent for utilization of patient data and publication of the consequent papers was obtained from all subjects involved in the study at the moment of in-hospital registration, as per the local law statement. Consent for publication Written informed consent for utilization of patient data and publication of the consequent papers was obtained from all subjects involved in the study at the moment of in-hospital registration, as per the local law statement. Competing interests Dr. Giuseppe Ietto is a Guest Editor in the Collection Kidney Transplantation. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Giuseppe Ietto, Email: giuseppe.ietto@asst-settelaghi.it. K. T.-CEUS Workgroup: Andrea Ballabio, Sebastiano Gerosa, Niccolò Grappolini, Domenico Iovino, Federica Masci, David Meierruth, Mauro Oltolina, Christian Ossola, Cristiano Parise, Walter Sirco, Andrea Vigezzi, and Elia Zani References Associated Data Data Availability Statement The datasets analysed during the current study are available from the corresponding author on reasonable request.